| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.08 | 0.08 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.08 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.09 |